Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1Breast 1

Conditions

Neoplasms 12Breast Neoplasms 11Prostatic Neoplasms 5Lung Neoplasms 5Colorectal Neoplasms 5Uterine Cervical Neoplasms 4Thyroid Neoplasms 2Smoking Cessation 2Motor Activity 2Lymphoma 2Hematologic Neoplasms 2Communication 2Uveal Melanoma 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tobacco Use Cessation 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Sexual Dysfunction, Physiological 1Sedentary Behavior 1Rectal Neoplasms 1Patient Preference 1Patient Acceptance of Health Care 1Papillomavirus Infections 1Papillary Thyroid Microcarcinoma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Melanoma 1

Interventions

Ipilimumab 17Nivolumab 15incomplete Freund's adjuvant 8Cyclophosphamide 7CTLA-4 Antigen 7pembrolizumab 6Ranibizumab 6sargramostim 5Radiosurgery 5Blood Specimen Collection 5tebentafusp 4Temozolomide 4Surveys and Questionnaires 4Magnetic Resonance Spectroscopy 4MART-1 Antigen 4Granulocyte-Macrophage Colony-Stimulating Factor 4Biopsy 4Bevacizumab 4fludarabine phosphate 3fludarabine 3aflibercept 3Thalidomide 3Sunitinib 3Specimen Handling 3MAGEA3 protein, human 3Interleukin-2 3130-nm albumin-bound paclitaxel 3relatlimab 2olaparib 2montanide ISA 51 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Uveal Melanoma × Focus Groups × Clear all
NCT04118062 2025-09-19

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Institut Curie

Phase NA Completed
128 enrolled
BreastDermatologic

Uveal Melanoma, Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡